Karim, Salim

Publications

Sort by

Co-Author Network

selected publications

Novel polymorphic and copy number diversity in the antibody IGH locus of South African individuals. Immunogenetics. 2024 Academic Article GET IT
Mpox: an old disease poses a new threat. Bulletin of the World Health Organization. 2024 Editorial Article GET IT
Strengthening and expanding capacities in clinical trials: advancing pandemic prevention, preparedness and response in Africa. Nature communications. 2024 Academic Article GET IT
Times cited: 2
Evaluating diagnostic accuracy of an RT-PCR test for the detection of SARS-CoV-2 in saliva. Diagnostic and prognostic research. 2024 Academic Article GET IT
Circulating immunoglobulins and transient lymphocytopenia in a sub-study of CAPRISA 012B, testing HIV monoclonal antibodies in a phase 1 trial. Scientific reports. 2024 Academic Article GET IT
The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus. PLoS pathogens. 2024 Academic Article GET IT
Incidence of herpes simplex virus type 2 positivity among women living with human immunodeficiency virus in South Africa. International journal of STD & AIDS. 2023 Academic Article GET IT
Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa. Diagnostic and prognostic research. 2023 Academic Article GET IT
Times cited: 137
Vaccine inequity and hesitancy persist-we must tackle both. BMJ (Clinical research ed.). 2023 Editorial Article GET IT
Times cited: 3
Building on Pasteur's legacy: producing vaccines in Africa. Lancet (London, England). 2022 Academic Article GET IT
Times cited: 1
A multinational Delphi consensus to end the COVID-19 public health threat. Nature. 2022 Academic Article GET IT
Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy-Accessing Participants: Incidence, Clinical Course, and Outcomes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022 Academic Article GET IT
Times cited: 7
Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa. The Journal of infectious diseases. 2022 Academic Article GET IT
Times cited: 6
The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet (London, England). 2022 Review GET IT
Times cited: 448
Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial. EClinicalMedicine. 2022 Academic Article GET IT
Times cited: 9
Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant. 2022 GET IT
Times cited: 357
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape. Cell host & microbe. 2022 Academic Article GET IT
Times cited: 147
SARS-CoV-2 evolved during advanced HIV disease immunosuppression has Beta-like escape of vaccine and Delta infection elicited immunity. 2021 GET IT
Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet (London, England). 2021 Academic Article GET IT
Times cited: 1017
HIV pre-exposure prophylaxis implementation in Africa: some early lessons. The Lancet. Global health. 2021 Academic Article GET IT
Times cited: 6
Institutional and behaviour-change interventions to support COVID-19 public health measures: a review by the Lancet Commission Task Force on public health measures to suppress the pandemic. International health. 2021 Review GET IT
Times cited: 40
A cluster-randomized controlled trial to improve the quality of integrated HIV-tuberculosis services in primary healthcareclinics in South Africa. Journal of the International AIDS Society. 2021 Academic Article GET IT
Times cited: 7
Should global financing be the main priority for pandemic preparedness?. Lancet (London, England). 2021 Letter GET IT
Times cited: 1
HIV incidence trends in Africa: young women at highest risk. The lancet. HIV. 2021 Academic Article GET IT
Times cited: 7
Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women. Frontiers in immunology. 2021 Academic Article GET IT
Times cited: 10
Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection. Lancet (London, England). 2021 Letter GET IT
Times cited: 42
Genital and systemic immune effects of the injectable, contraceptive norethisterone enanthate (NET-EN), in South African women. American journal of reproductive immunology (New York, N.Y. : 1989). 2021 Academic Article GET IT
Times cited: 1
Future scenarios for the COVID-19 pandemic. Lancet (London, England). 2021 Academic Article GET IT
Times cited: 130
SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet (London, England). 2021 Academic Article GET IT
Times cited: 420
Assessing a diagnosis tool for bacterial vaginosis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2020 Academic Article GET IT
Times cited: 9
HIV incidence rates in adolescent girls and young women in sub-Saharan Africa. The Lancet. Global health. 2019 Comment GET IT
Times cited: 80
The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation. Science translational medicine. 2019 Academic Article GET IT
Times cited: 134
Improving survival with tuberculosis & HIV treatment integration: A mini-review. The Indian journal of medical research. 2019 Review GET IT
Times cited: 9
Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy. Frontiers in microbiology. 2019 Academic Article GET IT
Times cited: 42
V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity. Cell reports. 2018 Academic Article GET IT
Times cited: 19
Optimising the accuracy of HIV drug resistance assays. The lancet. HIV. 2018 Comment GET IT
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection. Cell host & microbe. 2018 Academic Article GET IT
Times cited: 75
Acceptability of Early Antiretroviral Therapy Among South African Women. AIDS and behavior. 2018 Academic Article GET IT
Times cited: 20
Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women. Nature medicine. 2018 Academic Article GET IT
Times cited: 100
Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization. 2017 GET IT
Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope. Journal of virology. 2017 Academic Article GET IT
Times cited: 30
Closing the NIH Fogarty Center threatens US and global health. Lancet (London, England). 2017 Letter GET IT
Times cited: 2
Interleukin 1-Beta (IL-1β) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients. Journal of acquired immune deficiency syndromes (1999). 2017 Academic Article GET IT
Times cited: 17
Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. The lancet. HIV. 2016 Academic Article GET IT
Times cited: 219
Assessing progress with HIV incidence in national cohorts. The lancet. HIV. 2016 Comment GET IT
Times cited: 2
Efficacy and safety of tenofovir-containing antiretroviral therapy in women who acquired HIV while enrolled in tenofovir gel prophylaxis trials. Antiviral therapy. 2016 Academic Article GET IT
Times cited: 2
Social Context of Adherence in an Open-Label 1 % Tenofovir Gel Trial: Gender Dynamics and Disclosure in KwaZulu-Natal, South Africa. AIDS and behavior. 2016 Academic Article GET IT
Times cited: 16
Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women. AIDS (London, England). 2016 Academic Article GET IT
Times cited: 15
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection. PLoS pathogens. 2016 Academic Article GET IT
Times cited: 155
Is the UNAIDS target sufficient for HIV control in Botswana?. The lancet. HIV. 2016 Comment GET IT
Times cited: 7
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel. Mucosal immunology. 2016 Academic Article GET IT
Times cited: 11
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site. Cell reports. 2015 Academic Article GET IT
Times cited: 43
Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. Journal of immunology (Baltimore, Md. : 1950). 2015 Academic Article GET IT
Times cited: 22
South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication. Retrovirology. 2015 Academic Article GET IT
Times cited: 18
Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive. Journal of reproductive immunology. 2015 Academic Article GET IT
Times cited: 35
Appeal to global donors to save the Treatment Action Campaign. Lancet (London, England). 2014 Letter GET IT
Times cited: 2
Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies. BJOG : an international journal of obstetrics and gynaecology. 2014 Review GET IT
Times cited: 8
The need for multipurpose prevention technologies in sub-Saharan Africa. BJOG : an international journal of obstetrics and gynaecology. 2014 Academic Article GET IT
Times cited: 39
Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies. Cell host & microbe. 2014 Academic Article GET IT
Times cited: 121
HIV infection in high school students in rural South Africa: role of transmissions among students. AIDS research and human retroviruses. 2014 Academic Article GET IT
Times cited: 18
HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities. PloS one. 2014 Academic Article GET IT
Times cited: 29
HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women. Sexually transmitted infections. 2014 Academic Article GET IT
Times cited: 21
Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: results of a nested case-control study. AIDS and behavior. 2014 Academic Article GET IT
Times cited: 9
Impact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial. AIDS and behavior. 2014 Academic Article GET IT
Times cited: 21
Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial. AIDS and behavior. 2014 Academic Article GET IT
Times cited: 6
Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. AIDS care. 2014 Academic Article GET IT
Times cited: 16
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models. Virology journal. 2013 Academic Article GET IT
Times cited: 14
Changes to antiretroviral drug regimens during integrated TB-HIV treatment: results of the SAPiT trial. Antiviral therapy. 2013 Academic Article GET IT
Times cited: 19
No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial. PloS one. 2013 Academic Article GET IT
Times cited: 10
Topical microbicides--what's new?. Journal of acquired immune deficiency syndromes (1999). 2013 Academic Article GET IT
Times cited: 16
HIV pre-exposure prophylaxis in injecting drug users. Lancet (London, England). 2013 Comment GET IT
Times cited: 13
Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035. Journal of acquired immune deficiency syndromes (1999). 2013 Academic Article GET IT
Times cited: 18
Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design. Journal of virology. 2013 Academic Article GET IT
Times cited: 97
Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines. Vaccine. 2013 Review GET IT
Times cited: 25
Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression. AIDS (London, England). 2013 Academic Article GET IT
Times cited: 11
Changes in Natural Killer cell activation and function during primary HIV-1 Infection. PloS one. 2013 Academic Article GET IT
Times cited: 49
Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. The Journal of clinical investigation. 2012 Academic Article GET IT
Times cited: 161
Sustainability of task-shifting for antiretroviral treatment. Lancet (London, England). 2012 Letter GET IT
Times cited: 5
Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness. Journal of virology. 2012 Academic Article GET IT
Times cited: 10
Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial. Antiviral therapy. 2012 Academic Article GET IT
Times cited: 17
Antiretroviral prophylaxis for HIV prevention reaches a key milestone. Lancet (London, England). 2012 Letter GET IT
Times cited: 12
CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck. The Journal of infectious diseases. 2012 Academic Article GET IT
Times cited: 15
HIV prevalence among high school learners - opportunities for school-based HIV testing programmes and sexual reproductive health services. World health & population. 2012 Academic Article GET IT
Times cited: 6
Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstetrics and gynecology. 2011 Academic Article GET IT
Times cited: 29
Antiretroviral prophylaxis: a defining moment in HIV control. Lancet (London, England). 2011 Academic Article GET IT
Times cited: 90
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women. Lancet (London, England). 2011 Academic Article GET IT
Times cited: 198
HIV prevention transformed: the new prevention research agenda. Lancet (London, England). 2011 Review GET IT
Times cited: 231
Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011 Academic Article GET IT
Times cited: 66
Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial. Trials. 2011 Academic Article GET IT
Times cited: 27
Short communication decreased incidence of dual infections in South african subtype C-infected women compared to a cohort ten years earlier. AIDS research and human retroviruses. 2011 Academic Article GET IT
Times cited: 7
Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial. Contemporary clinical trials. 2011 Academic Article GET IT
Times cited: 20
Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. Journal of virology. 2010 Academic Article GET IT
Times cited: 69
Uptake of provider-initiated HIV testing and counseling among women attending an urban sexually transmitted disease clinic in South Africa - missed opportunities for early diagnosis of HIV infection. AIDS care. 2010 Academic Article GET IT
Times cited: 32
Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin. Virology. 2010 Academic Article GET IT
Times cited: 92
Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. AIDS (London, England). 2010 Academic Article GET IT
Times cited: 173
AIDS research must link to local policy. Nature. 2010 Academic Article GET IT
Times cited: 11
Salim "Slim" Abdool Karim: attacking AIDS in South Africa. Interview by Amy Maxmen. The Journal of experimental medicine. 2009 Article GET IT
Times cited: 1
Achieving the health Millennium Development Goals for South Africa: challenges and priorities. Lancet (London, England). 2009 Review GET IT
Times cited: 186
Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. The Journal of infectious diseases. 2009 Academic Article GET IT
Times cited: 66
Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. The Journal of infectious diseases. 2009 Academic Article GET IT
Times cited: 46
Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. Journal of immunology (Baltimore, Md. : 1950). 2009 Academic Article GET IT
Times cited: 73
Re: "Enhancement of HIV infection by cellulose sulfate," by Tao et al. AIDS research and human retroviruses. 2009 Letter GET IT
Times cited: 1
Scientists stand by decision to join Mbeki's AIDS panel. Nature. 2009 Letter GET IT
Times cited: 1
Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection. Virology journal. 2008 Academic Article GET IT
Times cited: 4
Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point. Journal of virology. 2008 Academic Article GET IT
Times cited: 47
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. Journal of virology. 2008 Academic Article GET IT
Times cited: 508
Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. The Journal of infectious diseases. 2008 Academic Article GET IT
Times cited: 63
Apnea and its possible relationship to immunization in ex-premature infants. Vaccine. 2008 Academic Article GET IT
Times cited: 15
Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage. PLoS pathogens. 2008 Academic Article GET IT
Times cited: 124
Perspective conducting HIV prevention research in South Africa. IAVI report : newsletter on international AIDS vaccine research. 2008 Article GET IT
Response to Brown et al., 'Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe'. AIDS (London, England). 2007 Letter GET IT
Times cited: 1
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection. Journal of virology. 2007 Academic Article GET IT
Times cited: 107
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. Journal of virology. 2007 Academic Article GET IT
Times cited: 246
Utilizing nucleic acid amplification to identify acute HIV infection. AIDS (London, England). 2007 Letter GET IT
Times cited: 11
HIV incidence estimates are key to understanding the changing HIV epidemic in South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2007 Editorial Article GET IT
Times cited: 2
Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa. AIDS research and human retroviruses. 2007 Academic Article GET IT
Times cited: 24
Durban 2000 to Toronto 2006: the evolving challenges in implementing AIDS treatment in Africa. AIDS (London, England). 2006 Academic Article GET IT
Times cited: 6
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. Journal of virology. 2006 Academic Article GET IT
Times cited: 321
Increasing burden of pulmonary tuberculosis in young women. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2006 Letter GET IT
Times cited: 1
Enrolling adolescents in research on HIV and other sensitive issues: lessons from South Africa. PLoS medicine. 2006 Academic Article GET IT
Times cited: 46
The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. Journal of acquired immune deficiency syndromes (1999). 2005 Academic Article GET IT
Times cited: 59
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. AIDS research and human retroviruses. 2005 Academic Article GET IT
Times cited: 20
Heterosexual transmission of multiple highly conserved viral variants in HIV-1 subtype C-infected seronegative women. AIDS (London, England). 2004 Academic Article GET IT
Times cited: 6
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. Journal of immunology (Baltimore, Md. : 1950). 2004 Academic Article GET IT
Times cited: 47
Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. The Journal of infectious diseases. 2004 Academic Article GET IT
Times cited: 93
A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting. Journal of acquired immune deficiency syndromes (1999). 2004 Academic Article GET IT
Times cited: 58
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. Journal of virology. 2004 Academic Article GET IT
Times cited: 187
Dual HIV-1 infection associated with rapid disease progression. Lancet (London, England). 2004 Academic Article GET IT
Times cited: 170
Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS (London, England). 2003 Academic Article GET IT
Times cited: 234
Report from the Tenth Retrovirus Conference. Vaccines and microbicides. AIDS clinical care. 2003 Conference Paper GET IT
Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS (London, England). 2003 Academic Article GET IT
Times cited: 103
Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS research and human retroviruses. 2003 Academic Article GET IT
Times cited: 110
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (London, England). 2002 Academic Article GET IT
Times cited: 714
A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. The Journal of antimicrobial chemotherapy. 2002 Academic Article GET IT
Times cited: 34
High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. Journal of acquired immune deficiency syndromes (1999). 2002 Academic Article GET IT
Times cited: 45
Characterization of full-length HIV type 1 subtype C sequences from South Africa. AIDS research and human retroviruses. 2001 Academic Article GET IT
Times cited: 49
Public-private health sector partnerships for STD control in South Africa--perspectives from the Hlabisa experience. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2001 Academic Article GET IT
Times cited: 6
Clinical testing of microbicides: a global research priority. AIDS (London, England). 2001 Editorial Article GET IT
Times cited: 1
The fate of free male condoms distributed to the public in South Africa. AIDS (London, England). 2001 Academic Article GET IT
Times cited: 27
Socioeconomic and cultural influence in the causation of burns in the urban children of Bangladesh. The Journal of burn care & rehabilitation. 2001 Academic Article GET IT
Times cited: 62
Syndrome packets and health worker training improve sexually transmitted disease case management in rural South Africa: randomized controlled trial. AIDS (London, England). 2000 Academic Article GET IT
Times cited: 45
Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world. AIDS (London, England). 2000 Academic Article GET IT
Times cited: 39
HIV surveillance results--little grounds for optimism yet. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 2000 Academic Article GET IT
Times cited: 10
Prevention of vertical transmission of HIV in South Africa. Paper did not include as a factor suboptimal effects that arise. BMJ (Clinical research ed.). 1999 Letter GET IT
Short course antiretroviral regimens to reduce maternal transmission of HIV. BMJ (Clinical research ed.). 1999 Editorial Article GET IT
Times cited: 14
Improving quality of sexually transmitted disease case management in rural South Africa. AIDS (London, England). 1998 Academic Article GET IT
Times cited: 36
Hospital inpatient audit--information for action. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 1998 Editorial Article GET IT
Times cited: 1
Is there a cure for AIDS?. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 1996 Conference Paper GET IT
Potential savings from generic prescribing and generic substitution in South Africa. Health policy and planning. 1996 Academic Article GET IT
Times cited: 48
Putting the records straight--a plea for improved abortion data. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. 1995 Editorial Article GET IT
Times cited: 2
Sex difference in measles fatality after introduction of new measles vaccine. Lancet (London, England). 1994 Letter GET IT
Times cited: 1

more ...

less ...

Background

education and training

M.B.,Ch.B., University of KwaZulu-Natal, Nelson R. Mandela School of Medicine (South Africa) 83
Ph.D., University of Natal (South Africa) 1999
M.S., Columbia University 1988

Contact

full name

Salim Karim

VIVO Weill Cornell Medical College

Salim Karim Adjunct Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name